Citadel Advisors »

Aytu Biopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Aytu Biopharma (AYTU) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Aytu Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aytu Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aytu Biopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $37k 12k 3.04

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Aytu Biopharma

Nantahala Capital Management
Geode Capital Management
Vanguard Group
BlackRock
Dimensional Fund Advisors
Acadian Asset Management
Northern Trust
Goldman Sachs Group
Citadel Advisors
Tower Research Capital
Royal Bank of Canada
Morgan Stanley
UBS Group
Jpmorgan Chase & Co
Advisor Group Holdings

View all funds holding Aytu Biopharma